HASEGAWA Minoru

FacultySensory and Locomotor Medicine, Dermatology
Teacher OrganizationSensory and Locomotor Medicine
Education and
 Research Organization
Faculty of Medical Sciences, School of Medicine
PositionProfessor
Last Updated: 19/07/23 18:55

Researcher Profile & Settings

Name

    HASEGAWA Minoru

Affiliation

  •  Sensory and Locomotor Medicine, Dermatology Professor

Education

  • 1991Kanazawa University

Research Activities

Published Papers

  • Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis.
    Koizumi H, Tokuriki A, Oyama N, Ido H, Sugiura K, Akiyama M, Hasegawa M.
    J Dermatol. 44(6) 723-724 Refereed
  • Erythema induratum of Bazin which occurred after tumor necrosis factor antagonist therapy.
    Baba N, Takashima W, Tokuriki A, Ameshima S, Hasegawa M.
    J Dermatol. 44 e87-e88 2017 Refereed
  • Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
    Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K
    Br J Dermatol. 176 395-402 Refereed
  • Survey of Single-Nucleotide Polymorphisms in the Gene Encoding Human Deoxyribonuclease I-like 2 Producing Loss of Function Potentially Implicated in the Pathogenesis of Parakeratosis
    M. Ueki, H.Takeshita, N.Utsunomiya, T. Chino, N. Oyama, M. Hasegawa, K.i Kimura-Kataoka, J. ujihara, R. Iida, T. Yasuda
    PLoS ONE 12(4) e0175083 Apr.  2017 Refereed
  • Multiple subcutaneous cholesterol granulomas arising in eruptive vellus hair cysts:Acase report and published work review of 11 cases.
    Utsunomiya N, Oyama N, Chino T, Tokuriki A, Sakai Y, Imamura Y, Hasegawa M.
    J Dermatol. 44(4) 481-482 Apr.  2017 Refereed
  • Two novel missense mutations of STS gene underlie X-linked recessive ichthyosis:understanding of the mutational and structural spectrum.
    Oyama N,Matsuda M,Hamada T,Numata S,Teye K,Hashimoto T,Hasegawa M.
    J Eur Acdd Dermato Venereol 30(9) 1629-1631 Sep.  2016 Refereed
  • Human?Leukocyte?Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.
    Furukawa H, Oka S, Kawasaki A, Shimada K, Sugii S, Matsushita T, Hashimoto A, Komiya A, Fukui N, Kobayashi K, Osada A, Ihata A, Kondo Y, Nagai T, Setoguchi K, Okamoto A, Okamoto A, Chiba N, Suematsu E, Kono H, Katayama M, Hirohata S, Sumida T, Migita K, Hasegawa M, Fujimoto M, Sato S, Nagaoka S, Takehara K, Tohma S, Tsuchiya N.
    PLOS one. 11(6) e0154255 Apr.  2016 Refereed
  • Oropharyngeal?Dysphagia?in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies
    Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Oohata S, Okita H, Yahata T, Someya F, Inoue K, Murono S, Fujimoto M, Takehara K.
    PLOS one. 11(5) e0154746 Apr.  2016 Refereed
  • CD34-positive infantile myofibromatosis: Case report and review of hemangiopericytoma-like pattern tumors
    Kiyohara T, Maruta N, Iino S, Ido H, Tokuriki A, Hasegawa M
    J Dermatol. 43 1088-1091 2016 Refereed
  • Watermelon?stomach?and colon in a patient with diffuse cutaneous systemic sclerosis.
    Matsushita T, Hasegawa M, Takehara K
    Mod Rheumatol. 27(2) 376-377 May  2017 Refereed
  • The wound/burn guidelines - 1: Wounds in general.
    Inoue Y, Hasegawa M, Maekawa T, Le Pavoux A, Asano Y, Abe M, Ishii T, Ito T, Isei T, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M, Ogawa F, Kadono T, Kodera M, Kawakami T, Kawaguchi M, Kukino R, Kono T, Sakai K, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hashimoto A, Hayashi M, Fujimoto M, Fujiwara H, Matsuo K, Madokoro N, Yamasaki O, Yoshino Y, Tachibana T, Ihn H; Wound/Burn Guidelines Committee.
    J Dermatol. 43 357-375 Apr.  2016 Refereed
  • The wound/burn guidelines - 2: Guidelines for the diagnosis and treatment for pressure ulcers.
    Tachibana T, Imafuku S, Irisawa R, Ohtsuka M, Kadono T, Fujiwara H, Asano Y, Abe M, Ishii T, Isei T, Ito T, Inoue Y, Ohtsuka M, Ogawa F, Kodera M, Kawakami T, Kawaguchi M, Kukino R, Kono T, Sakai K, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hashimoto A, Hasegawa M, Hayashi M, Fujimoto M, Maekawa T, Matsuo K, Madokoro N, Yamasaki O, Yoshino Y, Le Pavoux A, Ihn H; Wound/Burn Guidelines Committee.
    J Dermatol. 43 469-506 Apr.  2016 Refereed
  • The wound/burn guidelines - 3: Guidelines for the diagnosis and treatment for diabetic ulcer/gangrene.
    Isei T, Abe M, Nakanishi T, Matsuo K, Yamasaki O, Asano Y, Ishii T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M, Ogawa F, Kadono T, Kodera M, Kawakami T, Kawaguchi M, Kukino R, Kono T, Sakai K, Takahara M, Tanioka M, Nakamura Y, Hashimoto A, Hasegawa M, Hayashi M, Fujimoto M, Fujiwara H, Maekawa T, Madokoro N, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H;Wound/Burn Guidelines Committee.
    J Dermatol. 43 591-619 May  2016 Refereed
  • The wound/burn guidelines - 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis.
    Fujimoto M, Asano Y, Ishii T, Ogawa F, Kawakami T, Kodera M, Abe M, Isei T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M,Kadono T, Kawaguchi M, Kukino R, Kono T, Sakai K, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hashimoto A, Hasegawa M,Hayashi M, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Yamasaki O, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee
    J Dermatol. 43 729-757 Jun.  2016 Refereed
  • The wound/burn guidelines - 5: Guidelines for the management of lower leg ulcers/varicose veins.
    Ito T, Kukino R, Takahara M, Tanioka M, Nakamura Y, Asano Y, Abe M, Ishii T, Isei T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M, Ogawa F, Kadono T, Kawakami T, Kawaguchi M, Kono T, Kodera M, Sakai K, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Yamasaki O, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H ;Wound/Burn Guidelines Committee
    J Dermatol. 43 853-868 2016 Refereed
  • The wound/burn guidelines - 6: Guidelines for the management of burns
    Yoshino Y, Ohtsuka M, Kawaguchi M, Sakai K, Hashimoto A, Hayashi M, Madokoro N, Asano Y, Abe M, Ishii T, Isei T, Ito T, Inoue Y,Imafuku S, Irisawa R, Ohtsuka M, Ogawa F, Kadono T, Kawakami T, Kukino R, Kono T, Kodera M, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hasegawa M, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Yamasaki O, Le Pavoux A, Tachibana T, Ihn H
    J Dermatol. 43 989-1010 2016
  • A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation.
    Matsushita T, Le Huu D, Kobayashi T, Hamaguchi Y, Hasegawa M, Naka K, Hirao A, Muramatsu M, Takehara K, Fujimoto M.
    J Allergy Clin lmmunol. 138(4) 1170-1182 Oct.  2016 Refereed
  • Decreased levels of regulatory B cells in patients with systemic sclerosis:association with autoantibody production and disease activity.
    Matsushita T,Hamaguchi Y,Hasegawa M,Takehara K,Fujimoto M.
    Rheumatology(Oxford). 55(2) 263-267 Feb.  2016 Refereed
  • Biomrkers in systemic sclerosis:their potential to predict clincal courses.
    Hasegawa M.
    J Dermatol. 43(1) 29-38 Jan.  2016 Refereed
  • Redefining cutaneous lupus erythematosus: a proposed internationnal consensus approach and results of a preliminary questionnaire.
    Merola JF, Nyberg F, Furukawa F, Goodfield MJ, Hasegawa M, Marinovic B, Szepietowski J, Dutz J, Werth VP.
    Lupus Sci Med. 2(1) e000085 Mar.  2015 Refereed
  • Use of dermoscopy in the evaluation of connective tissue diseases.
    Hasegawa M.
    Dermatol Clin Res. 1(3) 41-48 Oct.  2015 Refereed
  • Clinical and Immunologic Predictors Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti-RNA Polymerase III Autoantibodies
    Hamaguchi Y, Kodera M, Matsushita T,Hasegawa M, Inaba Y, Usuda T, Kuwana M, Takehara K, Fujimoto M.
    Arthritis & Rheumatology 67(4) 1045-1052 Apr.  2015 Refereed
  • Developing classifacation criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meeting
    Elman SA, Nyberg F, Furukawa F, Goodfield M, Hasegawa M, Marinovic B, Szepietowski J, Dutz J, Werth VP, Merola JF.
    International Journal of Women's Dermatology 2(2) 44-45 2016 Refereed
  • Up-regulated expression of fractalkine in patients with systemic sclerosis
    M.Hasegawa
    ANNALS OF THE RHEUMATIC DISEASES 64(1) 21-28 2005
  • Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis
    M.Hasegawa
    ANNALS OF THE RHEUMATIC DISEASES 63(11) 1514 2004
  • Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
    M.Hasegawa
     296 89 2004
  • Comparative Study of Serum Surfactant Protein-D and KL-6 Concentrations in Patients with Systemic Sclerosis as Markers for Monitoring the Activity of Pulmonary Fibrosis
    M.Hasegawa
     31(6) 1112 2004
  • Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells
    M.Hasegawa
     50(6) 1918 2004
  • Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation
    M.Hasegawa
     113(5) 940-948 2004
  • Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma
    M.Hasegawa
     122(3) 594-601 2004
  • Elevated circulating CD40L concentrations in patients with systemic sclerosis
    M.Hasegawa
     31(3) 514-519 2004
  • Mouse CD20 expression and function
    M.Hasegawa
     16(1) 119-129 2004
  • Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma
    M.Hasegawa
     50(1) 227-232 2004
  • A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension
    M.Hasegawa
     23(3) 266-268 2004
  • L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity
    M.Hasegawa
    JOURNAL OF IMMUNOLOGY 170(8) 4325-4334 2003
  • Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis
    M.Hasegawa
     120 542-547 2003
  • Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site
    M.Hasegawa
     171(6) 2855-2862 2003
  • Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis
    M.Hasegawa
     21(4) 429-436 2003
  • Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma
    M.Hasegawa
     207(2) 141 2003
  • Antiphospholipid antibody in localised scleroderma
    M.Hasegawa
     62(8) 771-774 2003
  • Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis
    M.Hasegawa
     30(7) 1524 2003
  • Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses
    M.Hasegawa
    IMMUNITY 17(713-723) 2002 2002
  • The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression
    M.Hasegawa
     168 2970-2978 2002
  • CD19 can regulate B lymphocyte signal transduction independent of complement activation
    M.Hasegawa
    J Immunol 167 3190-3200 2001
  • A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice
    M.Hasegawa
    J Immunol 167 2469-2478 2001
  • CD19 amplification of B lymphocyte Ca responses: a role for Lyn sequestration in extinguishing negative regulation
    M.Hasegawa
    J Biol Chem 276 44820-44827 2001
  • Clinical significance of anti-topoisomerase I antibody levels by ELISA in systemic sclerosis
    M.Hasegawa
    RHEUMATOLOGY 40 1135-1140 2001
  • Clinical significance of soluble CD31 in patients with systemic sclerosis:association with limited cutaneous systemic sclerosis
    M.Hasegawa
    J Rheumatol 28 2460-2465 2001
  • Elevated serum L-selectin levels and decreased L-selectin expression on CD8+ T lymphocytes in systemic sclerosis
    M.Hasegawa
    Clin Exp Immunol 124 474-479 2001
  • Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis
    M.Hasegawa
    Arch Dermatil Res 293 350-355 2001
  • Renal vascular damage in Japanese patients with systemic sclerosis
    M.Hasegawa
    RHEUMATOLOGY 40 406-409 2001
  • CD19, CD21 and CD22: multifaced response regulators of B lymphocyte signal transduction
    M.Hasegawa
     20 739-762 2001
  • Quantitative genetic variation in CD19 expression correlates with autoimmunity
    M.Hasegawa
    J Immunol 165 6636-6643 2000
  • Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody
    M.Hasegawa
    Arch Dermatol Res 292 55-59 2000
  • Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis
    M.Hasegawa
    DERMATOLOGY 200 196-201 2000
  • Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis
    M.Hasegawa
    J Rheumatol 27 2838-2842 2000
  • Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis
    M.Hasegawa
    J Rheumatol 27 149-154 2000
  • Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma
    M.Hasegawa
    J Rheumatol 27 1917-1921 2000
  • Steeber DA, Tedder TF, Sato S. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L- selectin expression
    M.Hasegawa
    Am J Pathol 157 237-247 2000
  • Augmented production of chemokines (monocyte chemotactic protein-1(MCP-1)), macrophage inflammatory protein-1α(MIP-1α)and MIP-1β) in patients with systemic sclerosis: MCP-1and MCP-1α may be involved in the development of pulmonary fibrosis
    M.Hasegawa
    Clin Exp Immunol 117 159-165 1999
  • Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: Soluble L-selectin levels indicate disease severity
    M.Hasegawa
    J Allergy Clin Immunol 104 163-168 1999
  • Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
    . Rheumatol 38 612-617 1999
  • Systemic sclerosis revealing T-cell lymphoma
    M.Hasegawa
    DERMATOLOGY 198 75-78 1999
  • Systemic sclerosis revealing T-cell lymphoma
    M.Hasegawa
     198 75-78 1999
  • : IL-13 Production by pripheral blood mononuclear cells from patients with atopic dermatitis
    M.Hasegawa
    DERMATOLOGY 196 377-381 1998
  • Antigen specificity of antihistone antibodies in systemic sclerosis
    M.Hasegawa
    Annals Rheumatic Diseases 57 470-475 1998
  • Autoantibodies against calpastatin in sera from patients with systemic sclerosis
    M.Hasegawa
    J Rheumatol 25 2135-2139 1998
  • Increased plasma granulocyte elastase levels in Behcet's disease
    M.Hasegawa
    J Rheumatol 25 326-328 1998
  • Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis
    M.Hasegawa
    J Rheumatol 25 308-313 1998
  • Sweet's syndrome associated with granulocyre colony-stimulating factor
    Eur J Dermatol 18 503-505 1998
  • Elevated serum levels of interleukin 4(IL- 4), IL-10, and IL-13 patients with systemic sclerosis
    M.Hasegawa
    J Rheumatol 24 328-332 1997
  • Elevated serum tumor necrosis factor-α levels in patients with systemic sclerosis; association with pulmonary fibrosis
    M.Hasegawa
    J Rheumatol 24 663-665 1997
  • Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma
    M.Hasegawa
    Melanoma Research 7 243-251 1997
  • Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
    Luong VH, Chino T, Oyama N, Matsushita T, Sasaki Y, Ogura D, Niwa SI, BiswasT, Hamasaki A, Fujita M, Okamoto Y, Otsuka M, Ihn H, Hasegawa M.
    Arthritis Res Ther. 20(1) 46 Mar.  2018 Refereed

Books etc

  • Systemic Sclerosis:Recent Advance in Basic and Translational Research.
    Hasegawa M.
    Biomarker.
    SpringerJapan 2015

Conference Activities & Talks

  • A novel small compound that antagonizes TGF-β/Smad signaling ameliorates bleomycin-induced skin fibrosis.
    Vu H.Luong, Chino T, Tokuriki A, Oyama N, Sasaki Y, Ogura D, Niwa S, Fujita M, Okamoto Y, Otsuka M, Ihn H, Hasegawa M.
    The 41th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Anti-CX3CL1 antiboby therapy attenuates the development of bleomycin-induced and growth factors-induced skin fibrosis in mice.
    Vu H.Luong, Chino T, Oyama N, Kuboi Y, Obara T, Machinaga A, Ogasawara H, Ikeda W, Imai T, Hasegawa M.
    The 45th Annual Meeting of the Japanese Society for Immunology Dec.  2016
  • A novel small compound that antagonizes TGF-β/Smad signaling ameliorates bleomycin-induced skin fibrosis.
    Vu H.Luong, Chino T, Tokuriki A, Oyama N, Sasaki Y, Ogura D, Niwa S, Fujita M, Okamoto Y, Otsuka M, Ihn H, Hasegawa M.
    The 41st Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Selective alteration of hemidesmosomal antigens in lichen sclerosus skin: an immunohistochemical study on confocal laser scanning microscope.
    Utsunomiya N, Oyama N, Chino T, Utsunomiya A, Hasegawa M.
    The 41th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Selective alteration of hemidesmosomal antigens in lichen sclerosus skin: an immunohistochemical study on confocal laser scanning microscope.
    Utsunomiya N, Oyama N, Chino T, Utsunomiya A, Hasegawa M.
    The 41th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Dermokine β/r deficiency causes the selective impairment of epidermal barrier function in mice.
    Utsunomiya A, , Chino T, Tokuriki A, Vu Huy Loung, Oyama N, Higashi K, Saito K, Hasegawa M.
    The 41th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Dermokine β/r deficiency causes the selective impairment of epidermal barrier function in mice.
    Utsunomiya A, , Chino T, Tokuriki A, Vu Huy Loung, Oyama N, Higashi K, Saito K, Hasegawa M.
    The 41th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Dual aspects of B cells in tumor immunity; B cells are capable of positive and negative regulation for tumorimmunity against B16 melanima.
    Kobayashi T, Matsushita T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K.
    The 41th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2016
  • Dermokine β/γdeficiency enhances imiquimod-induced psoriasis-like inflammation.
    Tokuriki A, Chino T, Vu H.Luong, Oyama N, Higashi K, Saito K, Hasegawa M.
    The 40th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2015
  • Anti-CX3CL1 monoclonal antiboby: a promising therapy for systemic sclerosis.
    Vu H.Luong, Chino T, Tokuriki A, Oyama N, Hasegawa M, Kuboi Y, Obara T, Yasuda N, Muramoto K, Imai T.
    The 40th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2015
  • A novel small compound that antagonizes TGFβ/Smad signaling ameliorates bleomycin-induced skin fibrosis.
    Vu H.Luong, 知野剛直、徳力 篤、長谷川 稔、尾山徳孝、藤田美歌子、岡本良成、大塚雅巳、尹  浩信
     Jan.  2016
  • Decreased Levels of Regulatory B cells in Patients with Systemic Sclerosis: Association with autoantibody production and disease activity.
    Matsushita T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K.
    The 40th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2015
  • Dermokine β/γdeficiency enhances imiquimod-induced psoriasis-like inflammation.
    Tokuriki A, Chino T, Vu H.Luong, Oyama N, Higashi K, Saito K, Hasegawa M.
    The 40th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2015
  • Anti-CX3CL1 monoclonal antiboby: a promising therapy for systemic sclerosis.
    Vu H.Luong, Chino T, Tokuriki A, Oyama N, Hasegawa M, Kuboi Y, Obara T, Yasuda N, Muramoto K, Imai T.
    The 40th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2015
  • New aspects of autoantibodies in collagen diseases.
    Hasegawa M
    The 40th Annual Meeting of the Japanese Society for Investigative Dermatology Dec.  2015
  • 多発単神経炎に対し免疫グロブリン大量療法が奏効した小血管炎の1例
    髙嶋 渉, 徳力 篤, 長谷川 稔
     Jan.  2015
  • 全身性強皮症の治療戦略
    長谷川 稔
     Jan.  2015
  • A cruicial role of L-selectin in C protein-induced experimental polymyositis of mice
    K. Oishi, Y. Hamaguch, T. Matsushita, M.Hasegawa, N. Okiyama, J.Dernedde, M. Weinhart,, R. Haag,, T.Ftedder, K. takehara,, M.Fujimoto
     Dec.  2014
  • 皮膚症状から見えてくる膠原病診療
    長谷川 稔
     Nov.  2014
  • 硬化萎縮苔癬
    長谷川 稔
     Nov.  2014
  • 『見逃さない!関節症性乾癬』
    長谷川 稔
     Sep.  2014
  • 爪甲色素線条として発症した手指爪甲下有棘細胞癌の1例
    飯野 志郎, 徳力 篤, 長谷川 稔, 丸田 直樹, 清原 隆宏, 光戸 勇
     Sep.  2014
  • インテグラ真皮欠損用グラフトを用いて再建した爪部悪性腫瘍の3例
    飯野 志郎, 馬場 夏希, 丸田 直樹, 佐藤 英, 安田 聖人, 徳力 篤, 清原 隆宏, 長谷川 稔
     Sep.  2014
  • インフリキシマブ二次無効後に軸索変性性ニューロパチーを発症した関節症性乾癬の1例
    徳力 篤, 山口 由佳, 長谷川 稔, 井戸 敏子
     Sep.  2014
  • 高度の多発単神経炎に対し免疫グロブリン大量療法が著効した分類不能型小血管炎の1例
    髙嶋 渉, 徳力 篤, 清原 隆宏, 長谷川 稔, 斎藤 敦子
     Sep.  2014
  • 関節症状を有する乾癬患者の検討
    長谷川 稔
     Aug.  2014
  • 皮膚症状と自己抗体からみていく膠原病診療
    長谷川 稔
     Aug.  2014
  • アセトアミノフェンのdrug-induced 1ympocyte stimulation test(DLST)陽性、human herpe virus (HHV)-1,HHV-4,HHV-5 再活性化とHHV-6陰性を認めたDrug Reaction with Eosinophlia and Systemic Symptoms(DRESS)症候群の1例
    東谷 佐知子, 糟野 健司, 森川 幸恵, 森田 紗由, 西川 雄大, 今田 麻美子, 横井 靖二, 横山 由就, 三上 大輔, 高橋 直生, 木村 秀樹, 髙嶋 渉, 酒巻 一平, 池ヶ谷 諭史, 山内 高弘, 岩崎 博道, 長谷川 稔, 上田 孝典, 岩野 正之
     Jul.  2014
  • 左耳垂部に生じた棘融解型有棘細胞癌の1例
    飯野 志郎, 山口 由佳, 知野 剛直, 井戸 英樹, 安田 聖人, 長谷川 稔, 今村 好章, 清原 隆宏, 佐藤 英
     Jul.  2014
  • 右臀部の皮下結節の1例
    井戸 英樹, 清原 隆宏, 長谷川 稔, 大越 忠和, 海崎 泰治
     Jul.  2014
  • 創傷・熱傷ガイドライン創傷一般~ガイドラインの再確認
    アンドレ・レパヴ―, 井上 雄二, 新谷 洋一, 辻田 淳, 長谷川 稔, 藤田 英樹
     Jun.  2014
  • Infantile digital fibromatosisの1例
    知野 剛直, 清原 隆宏, 澤井 孝宏, 長谷川 稔, 堀江 直世, 大越 忠和, 今村 好章, 小村 一浩
     Jun.  2014
  • myofibroma/myofibromatosisの疾患概念
    清原 隆宏, 岡本 祐之, 丸田 直樹, 髙嶋 渉, 長谷川 稔, 大越 忠和, 今村 好章
     Jun.  2014
  • 腺癌との鑑別を要したschwannomaの1例
    井戸 英樹, 清原 隆宏, 長谷川 稔, 大越 忠和, 海崎 泰治
     Jun.  2014
  • 浸潤型外陰部Paget病の1例
    飯野 志郎, 丸田 直樹, 馬場 夏希, 徳力 篤, 清原 隆宏, 長谷川 稔, 福岡 美友紀
     Jun.  2014
  • 膠原病:皮膚症状と自己抗体から早期診断を
    長谷川 稔
     Jun.  2014